Related Experiment Video
Updated: Jan 18, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Riboflavin (Vitamin B2) Accumulation Modulates Neuronal Cellular Homeostasis in Typical Brain Development and
Eulália Rebeca Silva-Araújo1,2,3, Eduardo Padrón-Hernández1,3,4, Ana Elisa Toscano5,6,7,8
1Graduate Program in Neuropsychiatry and Behavioral Sciences, Center for Medical Sciences, Federal University of Pernambuco, Recife, Pernambuco, 50670-901, Brazil.
Insights
Vitamin B2 (riboflavin) shows promise for brain development and cerebral palsy (CP). High-dose riboflavin supports energy metabolism, reduces oxidative stress, and improves mitochondrial function in preclinical models.
Area of Science:
- Neuroscience
- Biochemistry
- Developmental Biology
Background:
- The developing brain has high energy demands for oxidative stress regulation and myelination.
- Early brain insults can lead to mitochondrial dysfunction, potentially causing cerebral palsy (CP).
Purpose of the Study:
- To investigate the role and effects of high-dose vitamin B2 (riboflavin) in neurodevelopment and cerebral palsy models.
Main Methods:
- A rodent preclinical study administering high-dose vitamin B2 (100 mg/kg).
- Analysis of redox homeostasis markers (malondialdehyde, carbonyls, glutathione-S-transferase, superoxide dismutase).
- Mitochondrial morphometric and ultrastructural analyses, including myelin sheath thickness.
Main Results:
- Riboflavin accumulated in both healthy and CP brains, supporting neurodevelopment.
- Riboflavin maintained redox homeostasis and improved mitochondrial biogenesis and structure.
- Treatment reduced oxidative stress markers and improved myelin sheath integrity in CP models.
Conclusions:
- Vitamin B2 accumulation is a beneficial mechanism supporting brain energy homeostasis and mitochondrial function.
- Riboflavin demonstrates potential therapeutic benefits for neurodevelopmental disorders like CP.
Abstract:
The developing brain requires high energy demands and metabolic efforts to regulate oxidative stress and myelination. Early insults cause mitochondrial dysfunction and compromise these pathways, potentially leading to cerebral palsy (CP), a severe and incurable neurological disorder that begins in childhood. Through a rodent preclinical study, we demonstrated that vitamin B2 (riboflavin), administered at a high dose (100 mg/kg), is accumulated in healthy (B2C) or paralytic (B2CP) brains and participates in neurodevelopment. Redox homeostasis was maintained in B2C through decreased malondialdehyde and carbonyls and increased glutathione-S-transferase activity. In B2CP rodents, there was a reduction in carbonyls and increased superoxide dismutase activity. Mitochondrial morphometric analysis suggests that riboflavin treatment increases biogenesis in controls and reduces mitochondrial deformation in CP. Ultrastructural analysis revealed increased myelin sheath thickness in B2C. Additionally, myelin figure formation and mitochondrial and axonal disintegration in CP were reduced by B2. Our evidence supports vitamin B2 accumulation as a beneficial mechanism to support energy homeostasis and mitochondrial demands that occur during typical neurodevelopment or in the face of CP.
Related Concept Videos
Vitamins
Drugs Affecting Neurotransmitter Synthesis
Transcriptional Regulation: Riboswitches
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Inborn Errors of Metabolism
The Blood-brain Barrier

